Form D · Other Health Care
Nuo Therapeutics, Inc.
Houston, TX · CIK 0001091596
Offering snapshot reported Aug 4, 2025 · SEC filing
- Reported sold
- $791K Offering amount: $791K
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 30, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 4, 2025 | Initial | $791,418 | No comparison | 9 | SEC filing |
| Sep 23, 2024 | Initial | $849,125 | No comparison | 10 | SEC filing |
| May 22, 2024 | Initial | $650,875 | No comparison | 11 | SEC filing |
| Dec 22, 2023 | Initial | $962,500 | No comparison | 9 | SEC filing |
| Aug 8, 2023 | Initial | $1,035,000 | No comparison | 9 | SEC filing |
| May 19, 2022 | Initial | $407,757 | No comparison | 6 | SEC filing |
| May 6, 2022 | Initial | $3,550,000 | No comparison | 26 | SEC filing |
| Jun 12, 2018 | Initial | $500,000 | No comparison | 1 | SEC filing |
| May 20, 2016 | Initial | $7,500,000 | No comparison | 25 | SEC filing |
| Dec 10, 2013 | Initial | $3,000,000 | No comparison | 10 | SEC filing |
| Feb 15, 2012 | Initial | $21,000,000 | No comparison | 17 | SEC filing |
| Jul 26, 2011 | Initial | $600,000 | No comparison | 4 | SEC filing |
| Jul 26, 2011 | Initial | $1,300,000 | No comparison | 1 | SEC filing |
| May 4, 2011 | Initial | $325,000 | No comparison | 4 | SEC filing |
| Oct 19, 2010 | Initial | $146,853 | No comparison | 1 | SEC filing |
| Apr 22, 2010 | Initial | $3,650,000 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-553598
Source: Form D, filed Aug 4, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lawrence S Atinsky | Director |
| James Benson | Director |
| Peter Clausen | Executive |
| Joseph Del Guercio | Director |
| Lyle Hohnke | Director |
| Benson S. James | Director |
| David Jorden | Director, Executive |
| Stephen Keith | Director |
| Richard Kent | Director |
| Andrew Maslan | Executive |
| Mark T. Mcloughlin | Director |
| Mark Mc Loughlin | Director |
| Mark T. Mcloughun | Director |
| Craig B. Mendelsohn | Director |
| Craig B. Mendelson | Director |
| Paul Mintz | Director |
| Paul Mint Z | Director |
| Scott Pittman | Director |
| Martin P. Rosendale | Director, Executive |
| Steven Shallcross | Executive |
| Keith N. Stephen | Director |
| Patrick P. Vanek | Executive |
| Eric C Winzer | Director |
| C Eric Winzer | Director |
| C. Eric Winzer | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
8285 El Rio Suite 190
Houston, TX, 77054
Houston, TX, 77054